Lipid-induced epigenomic changes in human macrophages identify a coronary artery disease-associated variant that regulates PPAP2B Expression through Altered C/EBP-beta binding.

Genome-wide association studies (GWAS) have identified over 40 loci that affect risk of coronary artery disease (CAD) and the causal mechanisms at the majority of loci are unknown. Recent studies have suggested that many causal GWAS variants influence disease through altered transcriptional regulati...

Full description

Bibliographic Details
Main Authors: Michael E Reschen, Kyle J Gaulton, Da Lin, Elizabeth J Soilleux, Andrew J Morris, Susan S Smyth, Christopher A O'Callaghan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-04-01
Series:PLoS Genetics
Online Access:http://europepmc.org/articles/PMC4383549?pdf=render
_version_ 1828453615944073216
author Michael E Reschen
Kyle J Gaulton
Da Lin
Elizabeth J Soilleux
Andrew J Morris
Susan S Smyth
Christopher A O'Callaghan
author_facet Michael E Reschen
Kyle J Gaulton
Da Lin
Elizabeth J Soilleux
Andrew J Morris
Susan S Smyth
Christopher A O'Callaghan
author_sort Michael E Reschen
collection DOAJ
description Genome-wide association studies (GWAS) have identified over 40 loci that affect risk of coronary artery disease (CAD) and the causal mechanisms at the majority of loci are unknown. Recent studies have suggested that many causal GWAS variants influence disease through altered transcriptional regulation in disease-relevant cell types. We explored changes in transcriptional regulation during a key pathophysiological event in CAD, the environmental lipid-induced transformation of macrophages to lipid-laden foam cells. We used a combination of open chromatin mapping with formaldehyde-assisted isolation of regulatory elements (FAIRE-seq) and enhancer and transcription factor mapping using chromatin immuno-precipitation (ChIP-seq) in primary human macrophages before and after exposure to atherogenic oxidized low-density lipoprotein (oxLDL), with resultant foam cell formation. OxLDL-induced foam cell formation was associated with changes in a subset of open chromatin and active enhancer sites that strongly correlated with expression changes of nearby genes. OxLDL-regulated enhancers were enriched for several transcription factors including C/EBP-beta, which has no previously documented role in foam cell formation. OxLDL exposure up-regulated C/EBP-beta expression and increased genomic binding events, most prominently around genes involved in inflammatory response pathways. Variants at CAD-associated loci were significantly and specifically enriched in the subset of chromatin sites altered by oxLDL exposure, including rs72664324 in an oxLDL-induced enhancer at the PPAP2B locus. OxLDL increased C/EBP beta binding to this site and C/EBP beta binding and enhancer activity were stronger with the protective A allele of rs72664324. In addition, expression of the PPAP2B protein product LPP3 was present in foam cells in human atherosclerotic plaques and oxLDL exposure up-regulated LPP3 in macrophages resulting in increased degradation of pro-inflammatory mediators. Our results demonstrate a genetic mechanism contributing to CAD risk at the PPAP2B locus and highlight the value of studying epigenetic changes in disease processes involving pathogenic environmental stimuli.
first_indexed 2024-12-11T00:09:57Z
format Article
id doaj.art-e4ab5a295c9c4824b1024f6c1da003d8
institution Directory Open Access Journal
issn 1553-7390
1553-7404
language English
last_indexed 2024-12-11T00:09:57Z
publishDate 2015-04-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Genetics
spelling doaj.art-e4ab5a295c9c4824b1024f6c1da003d82022-12-22T01:28:11ZengPublic Library of Science (PLoS)PLoS Genetics1553-73901553-74042015-04-01114e100506110.1371/journal.pgen.1005061Lipid-induced epigenomic changes in human macrophages identify a coronary artery disease-associated variant that regulates PPAP2B Expression through Altered C/EBP-beta binding.Michael E ReschenKyle J GaultonDa LinElizabeth J SoilleuxAndrew J MorrisSusan S SmythChristopher A O'CallaghanGenome-wide association studies (GWAS) have identified over 40 loci that affect risk of coronary artery disease (CAD) and the causal mechanisms at the majority of loci are unknown. Recent studies have suggested that many causal GWAS variants influence disease through altered transcriptional regulation in disease-relevant cell types. We explored changes in transcriptional regulation during a key pathophysiological event in CAD, the environmental lipid-induced transformation of macrophages to lipid-laden foam cells. We used a combination of open chromatin mapping with formaldehyde-assisted isolation of regulatory elements (FAIRE-seq) and enhancer and transcription factor mapping using chromatin immuno-precipitation (ChIP-seq) in primary human macrophages before and after exposure to atherogenic oxidized low-density lipoprotein (oxLDL), with resultant foam cell formation. OxLDL-induced foam cell formation was associated with changes in a subset of open chromatin and active enhancer sites that strongly correlated with expression changes of nearby genes. OxLDL-regulated enhancers were enriched for several transcription factors including C/EBP-beta, which has no previously documented role in foam cell formation. OxLDL exposure up-regulated C/EBP-beta expression and increased genomic binding events, most prominently around genes involved in inflammatory response pathways. Variants at CAD-associated loci were significantly and specifically enriched in the subset of chromatin sites altered by oxLDL exposure, including rs72664324 in an oxLDL-induced enhancer at the PPAP2B locus. OxLDL increased C/EBP beta binding to this site and C/EBP beta binding and enhancer activity were stronger with the protective A allele of rs72664324. In addition, expression of the PPAP2B protein product LPP3 was present in foam cells in human atherosclerotic plaques and oxLDL exposure up-regulated LPP3 in macrophages resulting in increased degradation of pro-inflammatory mediators. Our results demonstrate a genetic mechanism contributing to CAD risk at the PPAP2B locus and highlight the value of studying epigenetic changes in disease processes involving pathogenic environmental stimuli.http://europepmc.org/articles/PMC4383549?pdf=render
spellingShingle Michael E Reschen
Kyle J Gaulton
Da Lin
Elizabeth J Soilleux
Andrew J Morris
Susan S Smyth
Christopher A O'Callaghan
Lipid-induced epigenomic changes in human macrophages identify a coronary artery disease-associated variant that regulates PPAP2B Expression through Altered C/EBP-beta binding.
PLoS Genetics
title Lipid-induced epigenomic changes in human macrophages identify a coronary artery disease-associated variant that regulates PPAP2B Expression through Altered C/EBP-beta binding.
title_full Lipid-induced epigenomic changes in human macrophages identify a coronary artery disease-associated variant that regulates PPAP2B Expression through Altered C/EBP-beta binding.
title_fullStr Lipid-induced epigenomic changes in human macrophages identify a coronary artery disease-associated variant that regulates PPAP2B Expression through Altered C/EBP-beta binding.
title_full_unstemmed Lipid-induced epigenomic changes in human macrophages identify a coronary artery disease-associated variant that regulates PPAP2B Expression through Altered C/EBP-beta binding.
title_short Lipid-induced epigenomic changes in human macrophages identify a coronary artery disease-associated variant that regulates PPAP2B Expression through Altered C/EBP-beta binding.
title_sort lipid induced epigenomic changes in human macrophages identify a coronary artery disease associated variant that regulates ppap2b expression through altered c ebp beta binding
url http://europepmc.org/articles/PMC4383549?pdf=render
work_keys_str_mv AT michaelereschen lipidinducedepigenomicchangesinhumanmacrophagesidentifyacoronaryarterydiseaseassociatedvariantthatregulatesppap2bexpressionthroughalteredcebpbetabinding
AT kylejgaulton lipidinducedepigenomicchangesinhumanmacrophagesidentifyacoronaryarterydiseaseassociatedvariantthatregulatesppap2bexpressionthroughalteredcebpbetabinding
AT dalin lipidinducedepigenomicchangesinhumanmacrophagesidentifyacoronaryarterydiseaseassociatedvariantthatregulatesppap2bexpressionthroughalteredcebpbetabinding
AT elizabethjsoilleux lipidinducedepigenomicchangesinhumanmacrophagesidentifyacoronaryarterydiseaseassociatedvariantthatregulatesppap2bexpressionthroughalteredcebpbetabinding
AT andrewjmorris lipidinducedepigenomicchangesinhumanmacrophagesidentifyacoronaryarterydiseaseassociatedvariantthatregulatesppap2bexpressionthroughalteredcebpbetabinding
AT susanssmyth lipidinducedepigenomicchangesinhumanmacrophagesidentifyacoronaryarterydiseaseassociatedvariantthatregulatesppap2bexpressionthroughalteredcebpbetabinding
AT christopheraocallaghan lipidinducedepigenomicchangesinhumanmacrophagesidentifyacoronaryarterydiseaseassociatedvariantthatregulatesppap2bexpressionthroughalteredcebpbetabinding